Primer: Vaxxas (VAXXAS AU) - May 2026
Vaxxas is a clinical-stage biotechnology company at the forefront of developing a disruptive, needle-free vaccine delivery platform, the...
84 Views
No more insights
𝛼SK or SearchENTITY
Vaxxas (VAXXAS AU)
Vaxxas (VAXXAS AU)
1
Analysis
Health Care • Australia
The company develops a needle-free vaccine delivery system designed to enhance the performance of existing and next-generation vaccines. Its technology utilizes an array of vaccine-coated microprojections that perforate the outer layers of the skin to deposit vaccines directly among immune cells. The firm serves the healthcare and biotechnology sectors.
morex